Patrick Blin
Impact in
- Toxicology top 0.5%
- Pharmacovigilance and Adverse Drug Reactions
- Geriatrics and Gerontology top 2%
- Pharmaceutical Practices and Patient Outcomes
Papers in
-
- Atrial Fibrillation Management and Outcomes 15
- Antiplatelet Therapy and Cardiovascular Diseases 9
- Acute Myocardial Infarction Research 8
- Toxicology 12
- Pharmacovigilance and Adverse Drug Reactions 12
- Co-authors
- Nicholas D Moore (74 shared papers)Cécile Droz‐Perroteau (62 shared papers)R. Lassalle (54 shared papers)Mai Duong (6 shared papers)Julien Bezin (3 shared papers)Pauline Bosco‐Lévy (13 shared papers)Abdelilah Abouelfath (22 shared papers)Benoît Veber (2 shared papers)
- Journals
- Pharmacoepidemiology and Drug Safety (16 papers)British Journal of Clinical Pharmacology (11 papers)Drug Safety (6 papers)Value in Health (5 papers)European Heart Journal (3 papers)
- Partner nations
- FranceUnited KingdomNetherlands
In The Last Decade
Patrick Blin
143 papers receiving 3.5k citations
Patrick Blin's Hit Papers
Peers
Comparison fields: 5 of 129
- Toxicology 240
- Geriatrics and Gerontology 141
- Cardiology and Cardiovascular Medicine 630
- Pharmacology 316
- Applied Microbiology and Biotechnology 46
Countries citing papers authored by Patrick Blin
This map shows the geographic impact of Patrick Blin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrick Blin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrick Blin more than expected).
Fields of papers citing papers by Patrick Blin
This network shows the impact of papers produced by Patrick Blin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrick Blin. The network helps show where Patrick Blin may publish in the future.
Co-authors
The 25 scholars most cited alongside Patrick Blin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 152 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The national healthcare system claims databases in France, SNIIRAM and EGB: Powerful tools for pharmacoepidemiology Hit paper breakdown → | 2017 | 453 |
| 2 | 2006 | 281 | |
| 3 | 2006 | 231 | |
| 4 | 1996 | 141 | |
| 5 | 2019 | 120 | |
| 6 | 1998 | 116 | |
| 7 | 2005 | 105 | |
| 8 | 2016 | 92 | |
| 9 | 2013 | 83 | |
| 10 | 1988 | 76 | |
| 11 | 2012 | 76 | |
| 12 | 2015 | 72 | |
| 13 | 2017 | 70 | |
| 14 | 2018 | 61 | |
| 15 | 2020 | 61 | |
| 16 | 2006 | 59 | |
| 17 | 2013 | 59 | |
| 18 | 2014 | 58 | |
| 19 | 2021 | 58 | |
| 20 | 2018 | 56 |
About Patrick Blin
Patrick Blin is a scholar working on Cardiology and Cardiovascular Medicine, Toxicology, Pharmacology, Pharmacology and Economics and Econometrics, having authored 152 papers that have together received 3.7k indexed citations. Recurring topics across this work include Atrial Fibrillation Management and Outcomes (15 papers), Pharmacovigilance and Adverse Drug Reactions (12 papers), Inflammatory mediators and NSAID effects (12 papers), Pharmaceutical Economics and Policy (11 papers), Drug-Induced Hepatotoxicity and Protection (9 papers), Antiplatelet Therapy and Cardiovascular Diseases (9 papers), Acute Myocardial Infarction Research (8 papers) and Health Systems, Economic Evaluations, Quality of Life (8 papers). The work is most often cited by research in Toxicology (240 citations), Geriatrics and Gerontology (141 citations), Cardiology and Cardiovascular Medicine (630 citations), Pharmacology (316 citations) and Applied Microbiology and Biotechnology (46 citations). Patrick Blin has collaborated with scholars based in France, United Kingdom and Netherlands. Frequent co-authors include Nicholas D Moore, Cécile Droz‐Perroteau, R. Lassalle, Mai Duong, Julien Bezin, Pauline Bosco‐Lévy, Abdelilah Abouelfath, Benoît Veber, Hervé Dupont and Philippe Montravers. Their work appears in journals such as Pharmacoepidemiology and Drug Safety, British Journal of Clinical Pharmacology, Drug Safety, Value in Health and European Heart Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.